1 week Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates Zacks

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -75% and 33%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?